Literature DB >> 17074537

Cardiovascular disease 2005--the global picture.

Allan D Callow1.   

Abstract

Although the past twenty years have seen a remarkable decline in the death rates of heart disease and stroke in the United States and several countries of western Europe, a reverse trend is occurring in other parts of the world. This is especially true in sub-Saharan Africa, India, China and Russia. World-wide, deaths from cardiovascular disease exceed those caused by cancer, infectious disease and trauma, constituting a deadly epidemic. Yet, in 1996 the Victoria Declaration stated that the world has the knowledge to eliminate cardiovascular disease as a major illness. Defeating such an initiative are other priorities such as education, housing, transportation, defense, as well as ignorance. The Earth Institute has labeled the needed effort, "A Race Against Time".

Entities:  

Mesh:

Year:  2006        PMID: 17074537     DOI: 10.1016/j.vph.2006.08.010

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  27 in total

1.  Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study.

Authors:  Soo Lim; Jaeyoung Hong; Ching-Ti Liu; Marie-France Hivert; Charles C White; Joanne M Murabito; Christopher J O'Donnell; Josée Dupuis; Jose C Florez; James B Meigs
Journal:  Atherosclerosis       Date:  2013-04-22       Impact factor: 5.162

Review 2.  Insulin resistance, hyperglycemia, and atherosclerosis.

Authors:  Karin E Bornfeldt; Ira Tabas
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

Review 3.  Caloric restriction and chronic inflammatory diseases.

Authors:  O A González; C Tobia; J L Ebersole; M J Novak
Journal:  Oral Dis       Date:  2011-07-13       Impact factor: 3.511

4.  Inhibited proliferation of human umbilical artery smooth muscle cells by xanthinol nicotinate.

Authors:  Xiaodan Bai; Lijun Huang; Kejie Hu; Fujun Qu
Journal:  Med Biol Eng Comput       Date:  2015-12-30       Impact factor: 2.602

5.  Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.

Authors:  Alessandro Baldan; Silvia Ferronato; Silvia Olivato; Giovanni Malerba; Alberto Scuro; Gian Franco Veraldi; Matteo Gelati; Sergio Ferrari; Sara Mariotto; Pier Franco Pignatti; Sara Mazzucco; Macarena Gomez-Lira
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

6.  Apolipoprotein A-IV enhances cholecystokinnin secretion.

Authors:  Jesse Zhan; Jonathan Weng; Brian G Hunt; W Sean Davidson; Min Liu; Chunmin C Lo
Journal:  Physiol Behav       Date:  2018-01-31

7.  Apolipoprotein A-IV Enhances Fatty Acid Uptake by Adipose Tissues of Male Mice via Sympathetic Activation.

Authors:  Qi Zhu; Jonathan Weng; Minqian Shen; Jace Fish; Zhujun Shen; Karen T Coschigano; W Sean Davidson; Patrick Tso; Haifei Shi; Chunmin C Lo
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

8.  Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage.

Authors:  Yan Cao; Liang Wang; Junhong Zhao; Hongbing Zhang; Ying Tian; Houcheng Liang; Qiang Ma
Journal:  J Mol Neurosci       Date:  2016-01-23       Impact factor: 3.444

9.  Energy homeostasis in apolipoprotein AIV and cholecystokinin-deficient mice.

Authors:  Jonathan Weng; Danwen Lou; Stephen C Benoit; Natalie Coschigano; Stephen C Woods; Patrick Tso; Chunmin C Lo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-02       Impact factor: 3.619

10.  The relationship between lipoprotein-associated phospholipase A2 with cardiovascular risk factors in testosterone deficiency.

Authors:  Mustafa Keleşoğlu; Fuat Kızılay; Burcu Barutçuoğlu; Güneş Başol; Fulden Saraç; Işıl Mutaf; Bülent Semerci
Journal:  Turk J Urol       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.